Angel Qin
Clinical Associate Professor of Internal Medicine
Internal Medicine - Hematology/Oncology
1500 East Medical Center Drive
Ann Arbor, Michigan 48109
[email protected]

Available to mentor
Angel Qin
Clinical Associate Professor
  • Center Memberships
  • Recent Publications
    • Center Memberships
    • Center Member
      Rogel Cancer Center
    Recent Publications See All Publications
    • Journal Article
      Phase 2 Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients With Locally Advanced Non-Small Cell Lung Cancer.
      Edwards DM, Schonewolf CA, Rice JD, Schipper M, Haken RKT, Matuszak M, Balter J, Jarema D, Arenberg DA, Piert M, Qin A, Kalemkerian GP, Schneider BJ, Ramnath N, Chapman CH, Elliott DA, Lawrence TS, Hearn J, Hayman JA, Jolly S. Int J Radiat Oncol Biol Phys, 2024 Dec 1; 120 (5): 1332 - 1343. DOI:10.1016/j.ijrobp.2024.06.018
      PMID: 38971385
    • Journal Article
      Assessing the Tumor Immune Landscape Across Multiple Spatial Scales to Differentiate Immunotherapy Response in Metastatic Non-Small Cell Lung Cancer.
      Tsang AP, Krishnan SN, Eliason JN, McGue JJ, Qin A, Frankel TL, Rao A. Lab Invest, 2024 Nov; 104 (11): 102148 DOI:10.1016/j.labinv.2024.102148
      PMID: 39389312
    • Journal Article
      Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study.
      Leighl NB, Akamatsu H, Lim SM, Cheng Y, Minchom AR, Marmarelis ME, Sanborn RE, Chih-Hsin Yang J, Liu B, John T, Massutí B, Spira AI, Lee S-H, Wang J, Li J, Liu C, Novello S, Kondo M, Tamiya M, Korbenfeld E, Moskovitz M, Han J-Y, Alexander M, Joshi R, Felip E, Voon PJ, Danchaivijitr P, Hsu P-C, Silva Melo Cruz FJ, Wehler T, Greillier L, Teixeira E, Nguyen D, Sabari JK, Qin A, Kowalski D, Şendur MAN, Xie J, Ghosh D, Alhadab A, Haddish-Berhane N, Clemens PL, Lorenzini P, Verheijen RB, Gamil M, Bauml JM, Baig M, Passaro A, PALOMA-3 Investigators . J Clin Oncol, 2024 Oct 20; 42 (30): 3593 - 3605. DOI:10.1200/JCO.24.01001
      PMID: 38857463
    • Journal Article
      Management of Stage III Non-Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update.
      Daly ME, Singh N, Ismaila N, Management of Stage III NSCLC Guideline Expert Panel . J Clin Oncol, 2024 Sep 1; 42 (25): 3058 - 3060. DOI:10.1200/JCO-24-01324
      PMID: 39042842
    • Journal Article
      A phase 1/2, open label study of amivantamab in combination with tyrosine kinase inhibitors among participants with advanced NSCLC harboring ALK, ROS1, and RET gene fusions.
      Patil T, Martin AC, Wise HK, Schmitt E, Kuykendall H, Reventaite E, Filar E, Miller E, Yoder BA, Qin A, Schenk EL. Journal of Clinical Oncology, 2024 Jun 1; 42 (16_suppl): tps8661 - tps8661. DOI:10.1200/jco.2024.42.16_suppl.tps8661
    • Proceeding / Abstract / Poster
      A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
      Qin A, Wells L, Malhotra B, Gadgeel S, Schneider BJ, Ramnath N, Rice JD, Kalemkerian GP. Clin Lung Cancer, 2024 Mar; 25 (2): 128 - 134. DOI:10.1016/j.cllc.2023.10.011
      PMID: 37977950
    • Journal Article
      Selective Personalized RadioImmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial (SPRINT).
      Ohri N, Jolly S, Cooper BT, Kabarriti R, Bodner WR, Klein J, Guha C, Viswanathan S, Shum E, Sabari JK, Cheng H, Gucalp RA, Castellucci E, Qin A, Gadgeel SM, Halmos B. J Clin Oncol, 2024 Feb 10; 42 (5): 562 - 570. DOI:10.1200/JCO.23.00627
      PMID: 37988638
    • Journal Article
      Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2.
      Bazhenova L, Ismaila N, Abu Rous F, Alluri K, Freeman-Daily J, Halmos B, Malhotra N, Marrone KA, Puri S, Qin A, Leighl NB. J Clin Oncol, 2024 Nov 12; JCO2402133 DOI:10.1200/JCO-24-02133
      PMID: 39531596